Table 2 Cost analysis of the RT-PCR and Alere™ i Influenza A & B near patient testing strategies for patients with suspected influenza. Cells with italicized text identify the NPT testing strategy that provides the lowest cost and maximum saving for that line item
Costs per cohort of 1000 patients | ||||
|---|---|---|---|---|
Test | RT-PCR | Alere flu NPT with: | Maximum saving | |
Cost of: | Nasal swab | Throat swab | ||
Isolation | £295,356 | £104,489 | £71,298 | £231,334 |
Influenza testing | £70,000 | £23,450 | £82,571 | £46,550 |
Antiviral treatment | £10,294 | £4357 | £2395 | £7898 |
Nosocomial infection | £0 | £622 | £7529 | − £622 |
Total cost | £375,650 | £132,919 | £163,793 | £242,730 |